Clinical trial
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer…
NCT00253669 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00253669 |
|---|---|
| Title | Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas |
| Official title | Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH North American Brain Tumor Consortium |
| Status | Completed |
| Study type | Observational |
| Conditions | Brain and Central Nervous System Tumors, Thromboembolism |
| Intervention type | Other, Procedure |
| Interventions | laboratory biomarker analysis, physiologic testing, management of therapy complications |
| Enrollment | 110 |
| Start date | Apr 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Nov 15, 2005 |
| Last update posted | Jun 28, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: